The Way of the Psychonaut explores the life and work of Stanislav Grof, a psychedelic psychotherapy pioneer, creator of Holotropic Breathwork and founder of Transpersonal Psychology. Stan’s quest for knowledge influenced psychology and profoundly changed many lives.

Academy Award-winning filmmaker Alex Gibney and New York Times best-selling author Michael Pollan present this documentary series event in four parts, each focused on a different mind-altering substance: LSD, psilocybin, MDMA, and mescaline. With Pollan as our guide, we journey to the frontiers of the new psychedelic renaissance – and look back at almost-forgotten historical context – to explore the potential of these substances to heal and change minds as well as culture. How to Change Your Mind is directed by Emmy-nominated filmmaker Alison Ellwood and two-time Academy Award-nominated and Emmy-winning filmmaker Lucy Walker. SUBSCRIBE: http://bit.ly/29qBUt7 About Netflix: Netflix is the world's leading streaming entertainment service with 222 million paid memberships in over 190 countries enjoying TV series, documentaries, feature films and mobile games across a wide variety of genres and languages. Members can watch as much as they want, anytime, anywhere, on any internet-connected screen. Members can play, pause and resume watching, all without commercials or commitments. How to Change Your Mind | Official Trailer | Netflix https://youtube.com/Netflix Author Michael Pollan leads the way in this docuseries exploring the history and uses of psychedelics, including LSD, psilocybin, MDMA and mescaline.

The Interdisciplinary Conference on Psychedelic Research (ICPR) is Europe’s leading academic conference dedicated to advancing psychedelic research and therapies organised by the OPEN Foundation since 2010. ICPR is a biennial conference focused on high-quality scientific and scholarly research into psychedelics. *Get access to ICPR 2024 recordings* (lectures, talks, discussions): https://open-foundation.org/events/icpr/ Chapters: 00:00 Intro 01:17 What are psychedelics? Gül Dölen, MD, PhD. 02:25 What are the neurobiological mechanisms of psychedelics? Gül Dölen, MD, PhD. 03:16 The importance of psychedelic research in treating mental health problems. Pia Dijkstra, Minister of Healthcare, Government of The Netherlands. 04:08 How psychedlics help change the lives of clinical trial patients. Leonie Schneider, BSc & Ian Roullier, MA. 06:03 So psychedelics are the master keys, but what do they do in the brain? Gül Dölen, MD, PhD. 07:43 How could psychedelics treat obsessive compulsive disorder (OCD)? Jamila Hokanson, MD. 09:10 The potential of psychedelics to treat addiction. Wim van den Brink, MD, PhD. 10:06 What are the new research frontiers for MAPS? Rick Doblin, PhD. 11:17 How is psychedelic assisted psychotherapy different from traditional talking therapy? Janis Phelps, PhD. 12:44 How can we deal with the difficult, challenging psychedelic experiences? Rosalind Watts, PhD. 13:59 Why was there a need to create an organization for psychedelic trial patients? Leonie Schneider, BSc & Ian Roullier, MA. 14:33 There are many patients who are desperately waiting for legal access to psychedelic treatments. But there are also people who say that we move too fast, and we need to ensure ethical standards and the evidence base. How can we find a balance between the two? Leonie Schneider, BSc & Ian Roullier, MA. 15:51 Can psychedelic treatment find its way into mainstream care? Marc B. Aixalá and Nicolas Langlitz, MD, PHD., Elliot Marseille, DRPH, MPP. 19:21 The psychedelic renaissance vs. the counterculture. Eric Davies, PhD., Nicolas Langlitz, MD, PHD., Thomas Metzinger, PHD, 22:49 Psychedelics and the broader drug policy reform. Rick Doblin, PhD., Ethan Nadelmann, JD, PHD, 24:57 what would be the optimal regulation for non-medical use of psychedelics? Ethan Nadelmann, JD, PHD, 26:09 How could psychedelics move in betteer ways to the mainstream culture? Robert Jesse. 27:05 Psychedelic science and spirituality, mystical types of experiences. Robert Jesse. 28:26 Psychedelics and philosophy, the meaning of consciousness. Thomas Metzinger, PHD. ICPR features world-leading experts from many academic disciplines, including psychiatry, psychology, neuroscience, anthropology, ethnobotany, and philosophy who come together to give a scientific conference for academics, therapists, researchers, clinicians, policymakers, and members of the public. ICPR 2026 will be OPEN Foundation’s 7th edition. After our hugely successful conference in 2024, we are returning to the prestigious Philharmonie Theatre. *Sign Up to ICPR 2026 newsletter* (programme, ticket discounts & more): https://www.icpr-conference.com/stayt... The OPEN Foundation is the leading nonprofit organisation in the Netherlands and Europe that envisions a world where safe, beneficial, and accessible applications of psychedelics are ethically and responsibly integrated into science, healthcare, and society. The OPEN Foundation website: https://open-foundation.org/ Since 2007, the OPEN Foundation has been bringing together researchers, therapists, and other professionals from various backgrounds to stimulate critical and interdisciplinary discussion about psychedelics. We organise conferences, workshops, continuing education courses, expert meetings and other events. We engage members of the public with a nascent interest in psychedelic research and therapies, as well as specific target groups: academic researchers, (PhD) students, professional associations, policymakers, clinicians, and others. *Follow OPEN Foundation & ICPR* Instagram: / icpr_conference LinkedIn: / open-foundation Twitter / X: / open_fndn 🔔 Stay Connected with OPEN Foundation Subscribe for more updates and insights from ICPR and the psychedelic research community. ICPR Website: https://www.icpr-conference.com/ https://www.drugreporter.net https://www.facebook.com/drugreporter Reporter: Péter Sárosi | Rights Reporter Foundation - Drugreporter Camera and editing: István Gábor Takács | Rights Reporter Foundation - @DrugreporterTV